ResMed Sells MatrixCare Business for $490M, Plans Share Repurchase
RMD sits 21% above its 52-week low of $180.265.
Summary
ResMed announced the sale of its MatrixCare business for $490 million, a strategic divestiture to focus on core sleep and connected care markets, with proceeds earmarked for shareholder returns via an accelerated share repurchase.
Key Events · M&A and Partnerships · RMD
-
Divestiture of MatrixCare Business
ResMed entered a definitive agreement to sell its MatrixCare software business to Frazier Healthcare Partners for $490 million in an all-cash transaction.
-
Strategic Focus
The divestiture is part of ResMed's 2030 strategy to focus on high-growth, scalable opportunities in sleep health, breathing health, and connected home-based healthcare.
-
Financial Impact
The MatrixCare business represented approximately $220 million of revenue and $55 million of non-GAAP operating profit in fiscal year 2026.
-
Use of Proceeds
ResMed intends to use the net proceeds to return capital to shareholders, including through an accelerated share repurchase (ASR) program, and for general corporate purposes.
Analysis · RMD · Industrial Applications And Services
ResMed is divesting its MatrixCare software business for $490 million in cash to Frazier Healthcare Partners. This strategic move aims to sharpen ResMed's focus on its high-growth sleep and connected care markets. The company plans to use the net proceeds to return capital to shareholders through an accelerated share repurchase program and for general corporate purposes. While the divestiture means losing approximately $220 million in revenue and $55 million in non-GAAP operating profit, the strategic realignment and planned capital return are key aspects for investors to consider.
At the time of this filing, RMD was trading at $218.92 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $31.9B. The 52-week trading range was $180.27 to $293.81. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.